Pancreatic Cancer Research

ResearcherAffiliated Hospital of Nantong UniversityActive in the last 2 years

Haifeng Zhang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-1938-3796; OpenAlex author ID A5100399688. Sources: OpenAlex.

Their work

Papers
4 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
11
Papers, trials and grants by year

2015: 1 paper · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: 1 paper · 2023: none · 2024: none · 2025: 2 papers

Papers 4

  1. A scoring model for preoperative differentiation of high-enhancement pancreatic ductal adenocarcinoma from mass-forming chronic pancreatitis. Co-author DOI 10.1186/s12880-025-01830-x↗
  2. pH-sensitive Silk Fibroin Nanoparticles Encapsulating β-Hydroxyisovalerylshikonin for Targeted Pancreatic Cancer Therapy. Co-author DOI 10.2174/0115672018342718241030070142↗
  3. β-Hydroxyisovaleryl-Shikonin Exerts an Antitumor Effect on Pancreatic Cancer Through the PI3K/AKT Signaling Pathway. First author DOI 10.3389/fonc.2022.904258↗
  4. High expression of ErbB3 binding protein 1 (EBP1) predicts poor prognosis of pancreatic ductal adenocarcinoma (PDAC). Co-author DOI 10.1007/s13277-015-3625-6↗

Closest collaborators

The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Xiao Hu · 2 shared papers, 2022–2025 · strength 0.49
  2. Jiaping Zhou · 1 shared paper, 2025 · strength 0.30
  3. Yao Pan · 1 shared paper, 2025 · strength 0.30
  4. Risheng Yu · 1 shared paper, 2025 · strength 0.30
  5. Minghui Zhu · 1 shared paper, 2022 · strength 0.19
  6. Yu Zeng · 1 shared paper, 2022 · strength 0.19
  7. Gong Chen · 1 shared paper, 2015 · strength 0.05
  8. Xiaorong Liu · 1 shared paper, 2015 · strength 0.05
  9. Guoxiong Zhou · 1 shared paper, 2015 · strength 0.05
  10. Ji Li · 1 shared paper, 2015 · strength 0.05
  11. Chunhua Wan · 1 shared paper, 2015 · strength 0.05

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.